Mandashi

FourJaw Manufacturing Analytics is a provider of a machine-agnostic data analytics platform designed to enhance machining productivity through data-driven insights. The platform offers real-time visibility into shop floor operations, allowing users to monitor the status of each machine and identify unplanned downtime. By utilizing cloud-based technology, FourJaw enables small and medium-sized enterprises (SMEs) in the manufacturing sector to access critical analytics that support improved operational efficiency and productivity. Through its comprehensive approach, FourJaw aims to empower manufacturers with the tools necessary to optimize their processes and make informed decisions.

Hero of Health is an online platform that provides digital health management for people with chronic illnesses by promoting healthy aging.

GitLife Biotech specializes in providing a structured and centralized platform for synthetic biology, focusing on version control and biosecurity tools. The company’s technologies enhance reproducibility and proof of ownership in synthetic biology projects. By embedding proof of ownership directly within DNA, GitLife enables scientists to protect their innovations without the need for traditional patenting, which often requires disclosing sensitive DNA sequences. This approach not only safeguards intellectual property but also maintains the confidentiality of scientific recipes, allowing for greater flexibility in asset protection. Overall, GitLife Biotech aims to facilitate the development and scaling of synthetic biology by offering innovative solutions that prioritize security and ownership.

Ferrio is a business automation services company that focuses on developing a platform for automating complex processes and integrations. The platform is designed to enhance business efficiency by automating the sales process, allowing users to gather data from suppliers without the need for direct communication. Additionally, Ferrio's technology ensures that application programming interface connections remain current, thereby streamlining operations. By minimizing time-consuming and error-prone tasks, the company enables businesses to concentrate on activities that drive growth and optimize resource utilization.

Wild Hydrogen specializes in technology that converts unprocessed biomass into hydrogen and carbon dioxide under pressure. By developing systems that transform organic waste into clean energy, the company aims to reduce dependence on fossil fuels and enhance energy stability. Wild Hydrogen's innovative approach not only enables the production of affordable hydrogen with negative emissions but also contributes to carbon absorption during the production process. This technology facilitates a sustainable energy solution by ensuring zero emissions when the hydrogen is utilized.

Superbio.ai is a software-based data science and machine learning agency.

RareCan is an organization focused on enhancing research and improving outcomes for individuals with rare forms of cancer. It operates a direct-to-patient clinical trial platform that aims to expedite the processes involved in cancer research. By developing innovative patient and data pipelines, supported by proprietary technology, RareCan facilitates quicker and more cost-effective access for the pharmaceutical industry to the necessary patients and data. This initiative is designed to accelerate the development of precision medicine trials, thereby increasing the likelihood of successful outcomes in rare cancer treatments and ultimately contributing to the advancement of new therapies in the global cancer drug market.